Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:547586.
doi: 10.1155/2015/547586. Epub 2015 Jan 15.

Carcinoma in situ is significantly underdetected by prenephroureterectomy ureteroscopy in the management of upper tract urothelial cancers

Angela Gillan  1 , Ismail El-Mokadem  1 , Bhavan Rai  1 , Stephen Lang  2 , Jason Alcorn  3 , Altaf Shams Ud Din  4 , Ranan Dasgupta  4 , Chandra Shekhar Biyani  3 , Ghulam Nabi  1
Affiliations

Carcinoma in situ is significantly underdetected by prenephroureterectomy ureteroscopy in the management of upper tract urothelial cancers

Angela Gillan et al. Biomed Res Int. 2015.

Abstract

Objective. Diagnostic reliability of prenephroureterectomy ureteroscopy (PNU) for the detection of upper tract carcinoma in situ (CIS) remains unproven in particular and underreported in general. Methods. Patients who underwent radical nephroureterectomy (RNU) in a large multicentre retrospective study for upper tract transitional cell carcinoma (UT-TCC) between January 2002 and December 2013 were identified from our hospitals databases. PNU appearances, stage, and grade of ureteroscopic biopsy were compared with final histology results of RNU to assess the diagnostic reliability of PNU for carcinoma in situ (CIS). Results. Three hundred patients underwent RNU for UT-TCC. 106 (106/300; 35.3%) of the cohort had PNU using white light with biopsies taken in most (92/106; 86.7%). Postnephroureterectomy histology of the cohort showed CIS in 65 (65/300; 21.6%) patients. Thirty nine of patients with CIS (39/65; 60%) had prenephroureterectomy ureteroscopy biopsies. Out of ten patients with CIS on ureteroscopic biopsies, six did not show CIS on final histopathology (6/10; 60%). Moreover, grading and staging on PNU biopsies of obvious tumours showed a significant nonconcordance with final histopathology of RNU specimen (P = 0.02). Overall survival was also shorter in patients with CIS compared with those without; this showed strong statistical significance (P = 0.004). Conclusions. There is a high incidence of CIS in upper tract with significant underdetection and discordance rate between the histopathology of biopsy samples obtained by white light PNU and resected specimen of radical nephroureterectomy. The presence of concomitant CIS and high stage disease in the upper tract TCC carried a poor prognosis following radical nephroureterectomy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overall survival according to presence or absence of CIS in the upper urinary tract.
Figure 2
Figure 2
It shows up-/understaging of PNU histology including outcomes of inconclusive PNU biopsy specimens.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Rai B. P., Shelley M., Coles B., Somani B., Nabi G. Surgical management for upper urinary tract transitional cell carcinoma (UUT-TCC): a systematic review. BJU International. 2012;110(10):1426–1435. doi: 10.1111/j.1464-410X.2012.11341.x. - DOI - PubMed
    1. Chen G. L., Bagley D. H. Ureteroscopic surgery for upper tract transitional-cell carcinoma: complications and management. Journal of Endourology. 2001;15(4):399–404. doi: 10.1089/089277901300189420. - DOI - PubMed
    1. Daneshmand S., Quek M. L., Huffman J. L. Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience. Cancer. 2003;98(1):55–60. doi: 10.1002/cncr.11446. - DOI - PubMed
    1. Soderdahl D. W., Fabrizio M. D., Rahman N. U., Jarrett T. W., Bagley D. H. Endoscopic treatment of upper tract transitional cell carcinoma. Urologic Oncology: Seminars and Original Investigations. 2005;23(2):114–122. doi: 10.1016/j.urolonc.2004.10.010. - DOI - PubMed
    1. Cutress M. L., Stewart G. D., Wells-Cole S., Phipps S., Thomas B. G., Tolley D. A. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience. BJU International. 2012;110(11):1608–1617. doi: 10.1111/j.1464-410X.2012.11169.x. - DOI - PubMed

LinkOut - more resources